NSCLC cells treated with pemetrexed or 5-FU displayed a significant increase in PD-L1 levels on the cell surface (figure 1C, D), whereas cisplatin and PTX did not give such PD-L1 priming effects (online supplemental figure S1C, D). This evidence concerns the gene CD274 and non-small cell lung carcinoma.